Case number 1:21-cv-00228
Hikma Pharmaceuticals USA Inc. et al v. Aurobindo Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 17, 2021 | 17 | SO ORDERED (2) Docket Text: SO ORDERED, re [16] Stipulation of Dismissal filed by Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals LLC, (CASE CLOSED). Signed by Judge Colm F. Connolly on 8/16/2021. (nmf) |
| Aug 17, 2021 | 18 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,927,607; 9,399,036; 9,555,029; 9,675,613; 9,789,108. (nmf) |
| Aug 13, 2021 | 16 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal [Proposed] Consent Order of Dismissal by Hikma Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) |
| Jun 28, 2021 | 15 | SO ORDERED (2) Docket Text: SO ORDERED, re [14] Stipulation to Stay All Deadlines Pending Dismissal filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited, Case stayed. Signed by Judge Colm F. Connolly on 6/28/2021. (fms) |
| Jun 21, 2021 | 14 | Stipulation (2) Docket Text: STIPULATION to Stay All Deadlines Pending Dismissal by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Jun 9, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
| Jun 9, 2021 | 12 | Scheduling Order (18) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/28/2022. Amended Pleadings due by 3/28/2022. Fact Discovery completed by 4/18/2022. Expert Discovery due by 9/30/2022. Joint Claim Construction Brief due by 1/14/2022. A Markman Hearing is set for 2/15/2022 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 1/10/2023. A Final Pretrial Conference is set for 1/31/2023 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 2/13/2023 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 6/9/2021. (nmf) |
| Jun 9, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 6/9/2021. (dlb) |
| Jun 8, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the Proposed Scheduling Order has been replaced with a revised version to revise the language regarding the filing of dispositive motions for this ANDA case. (nmf) |
| Jun 8, 2021 | N/A | Remark (0) Docket Text: The 6/9/2021 Scheduling Conference is canceled. (nmf) |
| Jun 7, 2021 | 11 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Dominick T. Gattuso, Esquire regarding Proposed Scheduling Order. (Attachments: # (1) Text of Proposed Order [Proposed] Order)(Gattuso, Dominick) (Attachment 1 replaced on 6/8/2021) (nmf, ). |
| Jun 7, 2021 | 11 | Text of Proposed Order [Proposed] Order (18) |
| May 21, 2021 | 10 | Order Setting Scheduling Conference (2) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 6/9/2021 at 11:30 AM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 5/21/2021. (nmf) |
| Apr 27, 2021 | 8 | Answer to Complaint (17) Docket Text: ANSWER to [1] Complaint, by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Apr 27, 2021 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Mar 3, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles B. Klein for Hikma Pharmaceuticals LLC and Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Mar 2, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [6] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein and Sharon Lin of Winston & Strawn LLP filed by Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals LLC. Signed by Judge Colm F. Connolly on 3/2/2021. (nmf) |
| Feb 26, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals LLC: For Aurobindo Pharma Limited waiver sent on 2/26/2021, answer due 4/27/2021; Aurobindo Pharma USA, Inc. waiver sent on 2/26/2021, answer due 4/27/2021. (Gattuso, Dominick) |
| Feb 24, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Feb 19, 2021 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (amf) |
| Feb 19, 2021 | 6 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein and Sharon Lin of Winston & Strawn LLP - filed by Hikma Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) |
| Feb 18, 2021 | 1 | Main Document (15) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3530562.) - filed by Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals LLC. (Attachments: # (1) Exhibits A-E, # (2) Civil Cover Sheet)(amf) |
| Feb 18, 2021 | 1 | Exhibits A-E (101) |
| Feb 18, 2021 | 1 | Civil Cover Sheet (1) |
| Feb 18, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf) |
| Feb 18, 2021 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,927,607; 9,399,036; 9,555,029; 9,675,613; 9,789,108. (amf) |
| Feb 18, 2021 | 4 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/7/2021. Date of Expiration of Patent: 8/22/2033.Thirty Month Stay Deadline: 7/7/2023. (amf) |
| Feb 18, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceuticals, PLC for Hikma Pharmaceuticals LLC and Hikma Pharmaceuticals USA Inc. - filed by Hikma Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc. (amf) |
| Feb 18, 2021 | 1 | Complaint* (1) |
